Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Robot-assisted Renal Auto Transplantation: State of the Art.

European urology focus·2026
Same author

Corrigendum to "Robot-assisted Kidney Transplantation: The 8-year European experience" [Eur. Urol. 87(4) (2025) 468-475].

European urology·2026
Same author

Ten-year update on the European Association of Urology Robotic Section (ERUS) fellowship training for robot-assisted radical prostatectomy.

BJUI compass·2026
Same author

Robot-assisted Kidney Transplantation After ORAKTx.

European urology·2026
Same author

ProBIOPSY: A Multidisciplinary International Consensus on Standards for Prostate Biopsy.

European urology·2026
Same author

The Prognostic Value of Clinical and Pathological Response to Neoadjuvant Therapy in Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Systematic Review and Clinical Implications.

Cancers·2026

Related Experiment Video

Updated: Mar 14, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.9K

Robot assisted retroperitoneal lymph-node dissection after adjuvant therapy: different indications.

Victor E Corona Montes1,2, Antonio L Pastore3,4, Louis Gausa1

  • 1Department of Urology, Fundació Puigvert, Universidad Autónoma de Barcelona, Barcelona, Spain.

Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|September 30, 2016
PubMed
Summary

Robot-assisted retroperitoneal lymphadenectomy is a feasible surgical option for various cancers. This technique allows for precise lymph node dissection with no recurrence observed in a 39-month follow-up.

More Related Videos

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.7K
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

1.3K

Related Experiment Videos

Last Updated: Mar 14, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.9K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.7K
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

1.3K

Area of Science:

  • Urology
  • Surgical Oncology
  • Robotic Surgery

Background:

  • Robotic surgery offers urologists advanced tools for complex procedures like retroperitoneal lymphadenectomy.
  • It enables the reproduction of intricate surgical techniques with enhanced precision.

Purpose of the Study:

  • To report a series of robot-assisted retroperitoneal lymphadenectomies.
  • To demonstrate the technical and oncological feasibility of this approach.

Main Methods:

  • A retrospective analysis of 7 patients undergoing robot-assisted retroperitoneal lymphadenectomy.
  • Data collected included demographic, oncologic, and operative details (e.g., operative time, blood loss, hospital stay).

Main Results:

  • The mean operative time was 198 minutes with a mean blood loss of 88 mL.
  • An average of 12 lymph nodes were dissected with no intraoperative complications.
  • No disease recurrence was observed at a mean follow-up of 39 months.

Conclusions:

  • Robot-assisted retroperitoneal lymphadenectomy is a feasible and reproducible option in experienced centers.
  • The technology facilitates precise lymph node dissection, even in advanced oncologic cases.